"Antineoplastic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
| Descriptor ID |
D000970
|
| MeSH Number(s) |
D27.505.954.248
|
| Concept/Terms |
Antineoplastic Agents- Antineoplastic Agents
- Agents, Antineoplastic
- Antineoplastic Drugs
- Drugs, Antineoplastic
- Antineoplastics
- Chemotherapeutic Anticancer Drug
- Drug, Chemotherapeutic Anticancer
- Antitumor Drugs
- Drugs, Antitumor
- Cancer Chemotherapy Agents
- Agents, Cancer Chemotherapy
- Chemotherapy Agents, Cancer
- Cancer Chemotherapy Drugs
- Chemotherapy Drugs, Cancer
- Drugs, Cancer Chemotherapy
- Chemotherapeutic Anticancer Agents
- Agents, Chemotherapeutic Anticancer
- Anticancer Agents
- Agents, Anticancer
- Antitumor Agents
- Agents, Antitumor
|
Below are MeSH descriptors whose meaning is more general than "Antineoplastic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antineoplastic Agents".
This graph shows the total number of publications written about "Antineoplastic Agents" by people in this website by year, and whether "Antineoplastic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 3 | 1 | 4 |
| 1999 | 4 | 1 | 5 |
| 2000 | 1 | 1 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 6 | 3 | 9 |
| 2003 | 2 | 2 | 4 |
| 2004 | 4 | 2 | 6 |
| 2005 | 7 | 1 | 8 |
| 2006 | 10 | 5 | 15 |
| 2007 | 6 | 3 | 9 |
| 2008 | 9 | 4 | 13 |
| 2009 | 16 | 5 | 21 |
| 2010 | 17 | 8 | 25 |
| 2011 | 18 | 9 | 27 |
| 2012 | 15 | 7 | 22 |
| 2013 | 24 | 10 | 34 |
| 2014 | 22 | 6 | 28 |
| 2015 | 32 | 7 | 39 |
| 2016 | 36 | 8 | 44 |
| 2017 | 19 | 7 | 26 |
| 2018 | 25 | 7 | 32 |
| 2019 | 21 | 8 | 29 |
| 2020 | 22 | 5 | 27 |
| 2021 | 17 | 6 | 23 |
| 2022 | 12 | 0 | 12 |
| 2023 | 8 | 0 | 8 |
| 2024 | 7 | 12 | 19 |
| 2025 | 3 | 2 | 5 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antineoplastic Agents" by people in Profiles.
-
A novel recombinant arginine deiminase from Limosilactobacillus reuteri DSM 20016 demonstrates anticancer activity against colon cancer cells. Mol Biol Rep. 2026 Apr 10; 53(1).
-
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience. J Natl Cancer Inst. 2026 Apr 01; 118(4):655-668.
-
Regulated cell death in cancer: Mechanisms, crosstalk, and opportunities for therapy. Cancer Lett. 2025 Dec 28; 635:218077.
-
Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T. JCO Precis Oncol. 2025 Oct; 9:e2500119.
-
Sustained response to larotrectinib in a pediatric patient with recurrent STRN3::NTRK2 fusion-positive pilocytic astrocytoma. CNS Oncol. 2025 Dec; 14(1):2558455.
-
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids. SLAS Discov. 2025 Jun; 33:100230.
-
Focal adhesion kinase (FAK): emerging target for drug-resistant malignant tumors. Mol Biol Rep. 2025 Feb 20; 52(1):248.
-
Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein. J Med Chem. 2025 Jan 09; 68(1):81-94.
-
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer. J Pharmacol Exp Ther. 2025 Jan; 392(1):100004.
-
Anticancer and Antioxidant Properties of Vernonia amygdalina Delile and Citrus aurantifolia (Christm.) Swingle Juice Extracts: An In Vitro Study. Biomed Res Int. 2024; 2024:9692656.